266 related articles for article (PubMed ID: 22143953)
1. Aripiprazole augmentation treatment in treatment resistant bipolar depression: two patient reports.
Karadağ F; Tan D; Unal F
Turk Psikiyatri Derg; 2011; 22(4):269-72. PubMed ID: 22143953
[TBL] [Abstract][Full Text] [Related]
2. Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies.
Thase ME; Jonas A; Khan A; Bowden CL; Wu X; McQuade RD; Carson WH; Marcus RN; Owen R
J Clin Psychopharmacol; 2008 Feb; 28(1):13-20. PubMed ID: 18204335
[TBL] [Abstract][Full Text] [Related]
3. Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study.
Findling RL; Nyilas M; Forbes RA; McQuade RD; Jin N; Iwamoto T; Ivanova S; Carson WH; Chang K
J Clin Psychiatry; 2009 Oct; 70(10):1441-51. PubMed ID: 19906348
[TBL] [Abstract][Full Text] [Related]
4. Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study.
Schüle C; Baghai TC; Eser D; Hecht S; Hermisson I; Born C; Häfner S; Nothdurfter C; Rupprecht R
World J Biol Psychiatry; 2007; 8(2):112-22. PubMed ID: 17455104
[TBL] [Abstract][Full Text] [Related]
5. A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder.
Yatham LN
J Affect Disord; 2011 Jan; 128 Suppl 1():S21-8. PubMed ID: 21220077
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder.
Suppes T; Eudicone J; McQuade R; Pikalov A; Carlson B
J Affect Disord; 2008 Apr; 107(1-3):145-54. PubMed ID: 17904226
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the efficacy between paroxetine and sertraline augmented with aripiprazole in patients with refractory major depressive disorder.
Yoshimura R; Kishi T; Hori H; Ikenouchi-Sugita A; Katsuki A; Umene-Nakano W; Iwata N; Nakamura J
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):355-7. PubMed ID: 22813840
[TBL] [Abstract][Full Text] [Related]
8. Aripiprazole in major depression and mania: meta-analyses of randomized placebo-controlled trials.
Arbaizar B; Dierssen-Sotos T; Gómez-Acebo I; Llorca J
Gen Hosp Psychiatry; 2009; 31(5):478-83. PubMed ID: 19703642
[TBL] [Abstract][Full Text] [Related]
9. Adjunctive aripiprazole in treatment-resistant bipolar depression.
Ketter TA; Wang PW; Chandler RA; Culver JL; Alarcon AM
Ann Clin Psychiatry; 2006; 18(3):169-72. PubMed ID: 16923655
[TBL] [Abstract][Full Text] [Related]
10. Aripiprazole augmentation of antidepressants for the treatment of partially responding and nonresponding patients with major depressive disorder.
Simon JS; Nemeroff CB
J Clin Psychiatry; 2005 Oct; 66(10):1216-20. PubMed ID: 16259533
[TBL] [Abstract][Full Text] [Related]
11. Intramuscular aripiprazole in the control of agitation.
Currier GW; Citrome LL; Zimbroff DL; Oren D; Manos G; McQuade R; Pikalov AA; Crandall DT
J Psychiatr Pract; 2007 May; 13(3):159-69. PubMed ID: 17522559
[TBL] [Abstract][Full Text] [Related]
12. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
Lin CH; Lin SH; Jang FL
J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
[TBL] [Abstract][Full Text] [Related]
13. Aripiprazole augmentation in treatment-resistant bipolar depression: early response and development of akathisia.
Kemp DE; Gilmer WS; Fleck J; Straus JL; Dago PL; Karaffa M
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):574-7. PubMed ID: 17234318
[TBL] [Abstract][Full Text] [Related]
14. Aripiprazole in bipolar depression: a pooled, post-hoc analysis by severity of core depressive symptoms.
Thase ME; Bowden CL; Nashat M; Eudicone JM; Marcus R; McQuade RD; Carlson BX
Int J Psychiatry Clin Pract; 2012 Jun; 16(2):121-31. PubMed ID: 22296512
[TBL] [Abstract][Full Text] [Related]
15. Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial.
McElroy SL; Suppes T; Frye MA; Altshuler LL; Stanford K; Martens B; Leverich GS; Post RM; Keck PE
J Affect Disord; 2007 Aug; 101(1-3):275-81. PubMed ID: 17229469
[TBL] [Abstract][Full Text] [Related]
16. Augmentation of aripiprazole for depressed patients with an inadequate response to antidepressant treatment: a 6-week prospective, open-label, multicenter study.
Jon DI; Kim DH; Seo HJ; Kwon YJ; Kim MD; Yang JC; Suh HS; Min KJ; Pae CU; Bahk WM
Clin Neuropharmacol; 2013; 36(5):157-61. PubMed ID: 24045606
[TBL] [Abstract][Full Text] [Related]
17. Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole.
Zimbroff DL; Marcus RN; Manos G; Stock E; McQuade RD; Auby P; Oren DA
J Clin Psychopharmacol; 2007 Apr; 27(2):171-6. PubMed ID: 17414241
[TBL] [Abstract][Full Text] [Related]
18. Effect of aripiprazole on self-reported anhedonia in bipolar depressed patients.
Mazza M; Squillacioti MR; Pecora RD; Janiri L; Bria P
Psychiatry Res; 2009 Jan; 165(1-2):193-6. PubMed ID: 18973955
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of aripiprazole augmentation in Japanese patients with major depressive disorder: a subgroup analysis and Montgomery-Åsberg Depression Rating Scale and Hamilton Rating Scale for Depression item analyses of the Aripiprazole Depression Multicenter Efficacy study.
Ozaki N; Otsubo T; Kato M; Higuchi T; Ono H; Kamijima K;
Psychiatry Clin Neurosci; 2015 Jan; 69(1):34-42. PubMed ID: 24965202
[TBL] [Abstract][Full Text] [Related]
20. The effects of aripiprazole on the subscales of the Kellner Symptom Questionnaire in treatment resistant depression.
Dording C; Cassiello C; King F; Pencina M; Fava M; Mischoulon D
Int Clin Psychopharmacol; 2013 Sep; 28(5):238-44. PubMed ID: 23764521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
